AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
175.44
-0.14 (-0.08%)
Dec 23, 2024, 10:34 AM EST - Market open
AbbVie Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for AbbVie stock have an average target of 207.45, with a low estimate of 185 and a high estimate of 225. The average target predicts an increase of 18.24% from the current stock price of 175.44.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AbbVie stock from 22 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 8 | 9 | 8 |
Buy | 9 | 9 | 9 | 9 | 11 | 11 |
Hold | 1 | 1 | 1 | 3 | 2 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 14 | 14 | 14 | 20 | 22 | 22 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Buy Maintains $212 → $220 | Buy | Maintains | $212 → $220 | +25.40% | Dec 17, 2024 |
B of A Securities | B of A Securities | Hold Initiates $191 | Hold | Initiates | $191 | +8.87% | Dec 10, 2024 |
Leerink Partners | Leerink Partners | Hold → Buy Upgrades $206 | Hold → Buy | Upgrades | $206 | +17.42% | Nov 22, 2024 |
Wolfe Research | Wolfe Research | Buy Initiates $205 | Buy | Initiates | $205 | +16.85% | Nov 15, 2024 |
JP Morgan | JP Morgan | Buy Maintains $210 → $200 | Buy | Maintains | $210 → $200 | +14.00% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
57.18B
from 54.32B
Increased by 5.28%
Revenue Next Year
60.46B
from 57.18B
Increased by 5.73%
EPS This Year
11.16
from 2.72
Increased by 310.32%
EPS Next Year
12.43
from 11.16
Increased by 11.39%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 59.4B | 64.2B | 69.1B | |||
Avg | 57.2B | 60.5B | 64.9B | |||
Low | 54.7B | 55.1B | 60.0B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 9.4% | 12.3% | 14.2% | |||
Avg | 5.3% | 5.7% | 7.4% | |||
Low | 0.7% | -3.6% | -0.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 11.62 | 13.65 | 15.70 | |||
Avg | 11.16 | 12.43 | 13.99 | |||
Low | 10.68 | 11.30 | 12.75 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 327.3% | 22.3% | 26.3% | |||
Avg | 310.3% | 11.4% | 12.5% | |||
Low | 292.7% | 1.2% | 2.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.